Danger: Scientist Edits Human Embryo For The First Time & Injects A Person for the First Time, Setting Stage For Designer Babies and Rebirthing the Nephilim (UPDATED)

(UPDATED SEE BOTTOM OF POST) — Designer Babies are rapidly becoming a reality, for the first time a biologist from Sweden recently publicized his successful editing of human DNA in embryos. Mainly paving the way for both designer babies and removing the hand of God from creation.

Learn More About CRISPR in the Video Below

Read More: China’s Human Trials

Once mankind gets involved with editing how children are produced such as modifying DNA, the hand of God no longer remains in that creation. What will come about through genome editing and CRISPR/CAS9 technologies is something this world hasn’t seen since the Biblical Days of Old, the return of the Nephilim.

Developmental biologist Fredrik Lanner of the Karolinska Institutet in Stockholm, Sweden is the first to yield viable human embryos after gene editing and announce it to the public. Lanner was able to accomplish this achievement using the powerful gene-editing tool, CRISPR/Cas9. Upon further study into its specificity and potential as a DNA repair system, researchers at the Broad Institute of MIT and Harvard harnessed the CRISPR-Cas9 system to demonstrate its efficiency in eukaryotic cells.

Although Lanner’s research exists as a testament to the power of CRISPR/Cas9 and the progress geneticists are making, his study reignites many of the ethical debates initially sparked by previous attempts to edit human genes in viable embryos. That is, Lanner’s research invites scientists as well as the public to assess the morality and legality of editing the human genome.

Multiple arguments have been proposed both for and against humane genome editing. Supporters celebrate the ability to do so as a therapy to prevent embryos with a genetic predisposition to life-threatening or seriously debilitating diseases.

However, those in opposition argue that inviting scientists to edit the human genome will allow the manufacturing of “designer babies”: or made-to-order children with traits specified by parents or scientists.

Giving mankind full control over the ability to create “made-to-order” babies is a very, very bad idea. However, far worse than that is giving the cabalists capacity to use skin cells to rebirth the Nephilim. How could this possibly be done?

Scientists recently produced a technology that would allow babies to be born using skin cells and bypasses the standard step of fertilizing an egg cell with sperm. The study hints that eggs may not be unique in their ability to form embryos with sperm and that skin and other cells in the body could even take their place.

“Our work challenges the dogma, held since early embryologists first observed mammalian eggs around 1827 and observed fertilisation 50 years later, that only an egg cell fertilised with a sperm cell can result in live mammalian birth,” said Tony Perry, an embryologist and lead researcher on the project at Bath University.

“What we’re talking about are different ways of making embryos. Imagine that you could take skin cells and make embryos from them? This would have all kinds of utility,” he added.

Skin cells can be taken from very, very old and dead skeletons, which means that scientists could bring back the creatures of old, in fact, one professor had already proposed something very similar.

Professor George Church of Harvard Medical School believes he can reconstruct Neanderthal DNA and resurrect the species which became extinct 33,000 years ago. His scheme is reminiscent of Jurassic Park but, while in the film dinosaurs were created in a laboratory, Professor Church’s ambitious plan requires a human volunteer. He said his analysis of Neanderthal genetic code using samples from bones is complete enough to reconstruct their DNA.

He said: ‘Now I need an adventurous female human. ‘It depends on a hell of a lot of things, but I think it can be done.’ Professor Church’s plan would begin by artificially creating Neanderthal DNA based on genetic code found in fossil remains. He would put this DNA into stem cells. These would be injected into cells from a human embryo in the early stages of life.

It is thought that the stem cells would steer the development of the hybrid embryo on Neanderthal lines, rather than human ones.

The collusion of researchers could potentially produce the successful result of recreating a species of old. in fact, already proposed is the ideology of bringing back “extinct” animals.

Perhaps more immediately, the research might help conservationists to maintain populations of endangered animals by giving them an alternative way to make embryos from rare creatures that can be carried to term in surrogate mothers.

The combination of research and scientific progress is almost like a timetable. First they ‘discover’ this method and then they ‘discover’ that method. When in reality there is an end goal, and whether or not the scientists are aware of such a goal – either way, are giving the cabalists the methodology to bring back the ‘men of old, men of renown,’ or in other words the Nephilim.

Chinese researchers have become the first to inject a person with genes that have been modified using the CRISPR–Cas9 technique.

(NATURE) — A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR–Cas9 technique.

On 28 October, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer as part of a clinical trial at the West China Hospital, also in Chengdu.

Earlier clinical trials using cells edited with a different technique have excited clinicians. The introduction of CRISPR, which is simpler and more efficient than other techniques, will probably accelerate the race to get gene-edited cells into the clinic across the world, says Carl June, who specializes in immunotherapy at the University of Pennsylvania in Philadelphia and led one of the earlier studies.

“I think this is going to trigger ‘Sputnik 2.0’, a biomedical duel on progress between China and the United States, which is important since competition usually improves the end product,” he says.

June is the scientific adviser for a planned US trial that will use CRISPR to target three genes in participants’ cells, with the goal of treating various cancers. He expects the trial to start in early 2017. And in March 2017, a group at Peking University in Beijing hopes to start three clinical trials using CRISPR against bladder, prostate and renal-cell cancers. Those trials do not yet have approval or funding.